Global Home Infusion Therapy Market is anticipated to grow at a CAGR of 6.10% between 2022 and 2030.The global market for home infusion therapy is expanding significantly and changing the face of healthcare. Home infusion therapy involves the management of medications, nutrients, or other therapeutic retailers through intravenous or subcutaneous routes in the comfort of a patient’s home. This technique gives numerous advantages, which include improved patient comfort, reduced hospital stays, and decrease in healthcare charges.

The rising incidence of chronic diseases like cancer, autoimmune conditions, and infectious diseases is one of the main factors driving this market. Patients with chronic conditions often require long-term intravenous treatments, and home infusion therapy provides a viable alternative to hospital-based care. Moreover, the aging population, particularly in developed regions like North America and Europe, is contributing to the growth of this market, as elderly individuals are more likely to require ongoing medical treatments. So, the Global Home Infusion Therapy Market is anticipated to value around US$ 64.56 Billion by 2030.

Another huge factor propelling the home infusion therapy market is the advancement of scientific technology. Innovations in infusion pumps, catheters, and different scientific devices have made it more secure and accessible for patients to self-administer medicinal capsules or get help from skilled caregivers in their homes. Also, the growth of telehealth and remote tracking competencies has facilitated the monitoring and management of patients receiving home infusion therapy, further enhancing the general patient experience. The global home infusion therapy market is growing due to the recognition of minimizing healthcare facility exposure while maintaining care quality, a trend accentuated by the recent occurrences. Challenges like reimbursement, regulations, and training persist, yet the market is poised for expansion as healthcare systems adapt to changing patient needs, offering innovative home-based solutions for long-term intravenous therapies.

Request a free sample copy of the report:

Infusion pumps continue to dominate the home infusion therapy market due to their precision, reliability, and versatility.

Insulin pumps ensure correct drug transport and healing consistency, essential for patient protection and crucial at some stage in domestic remedies. Their programmable capabilities allow healthcare companies to tailor infusion regimens to individual patient needs, enhancing treatment efficacy. As the demand for home-based healthcare solutions grows, infusion pumps play a pivotal role in enabling patients to obtain complicated cures quite simply and securely in the acquainted surroundings in their houses, solidifying their dominant position in the market.

Products – Global Home Infusion Therapy Market has been covered from 4 viewpoints.

  1. Infusion Pumps
  2. Intravenous Sets
  3. IV Cannulas
  4. Needleless Connectors

Parenteral nutrients applications are experiencing rapid growth in the home infusion therapy market.

As more people require specialised vitamins and hydration therapies at home, parenteral nutrient infusions provide a lifeline. They make certain patients obtain vital vitamins intravenously, addressing situations like malnutrition or gastrointestinal disorders. The comfort and versatility of home-based vitamins therapy contribute to its fast improvement, as it offers a higher quality of life for patients while reducing the burden on healthcare centers.

Application – Global Home Infusion Therapy Market has been covered from 7 viewpoints.

  1. Anti-Infective
  2. Hydration Therapy
  3. Chemotherapy
  4. Internal Nutrition
  5. Parenteral Nutrition
  6. Specialty Pharmaceuticals
  7. Others

The United States leads the home infusion therapy market due to its well-established healthcare infrastructure, robust regulatory framework, and a growing aging population.

The United States has advanced healthcare system that supports the delivery of complex therapies at home, making it a preferred choice for patients seeking comfort and convenience. Moreover, a comprehensive reimbursement system and the presence of leading home infusion service providers contribute to the market’s dominance. The U.S. continues to prioritize home-based healthcare, fostering its leadership in the home infusion therapy sector.

Countries – Global Home Infusion Therapy Market has been covered from 26 viewpoints.

  1. United States
  2. Canada
  3. France
  4. Germany
  5. Italy
  6. Spain
  7. United Kingdom
  8. Belgium
  9. Netherlands
  10. Turkey
  11. China
  12. Japan
  13. India
  14. Australia
  15. South Korea
  16. Thailand
  17. Malaysia
  18. Indonesia
  19. New Zealand
  20. Brazil
  21. Mexico
  22. Argentina
  23. South Africa
  24. Saudi Arabia
  25. UAE
  26. ROW

Competitive Landscape.

The leading companies operating in the global home infusion therapy market arePfizer Inc, Smith & Nephew P.C., Terumo Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Baxter International Inc., ICU Medical, and Eli Lilly and Company.

Company Insights.

•        Overview

•        Recent Development and Initiatives

•        Sales Analysis

Analysis of the companies present in the global home infusion therapy market.

  1. Pfizer Inc,
  2. Smith & Nephew P.C.,
  3. Terumo Corporation,
  4. Johnson & Johnson Services, Inc.,
  5. Becton, Dickinson, and Company,
  6. Baxter International Inc.,
  7. ICU Medical,
  8. Eli Lilly and Company.

Browse Related Report:

Dental Diagnostics and Surgical Equipments Market:

Electric Wheelchair Market:

Atherectomy Devices Market:

Medical Adhesives Market:

Global Dialysis Market:

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)